Roche Calls for Global Healthcare Overhaul
Roche urges global healthcare reform to address rising chronic disease burden.
The Economic Times · 1m
Indian Pharma Risk Aversion
Indian pharma leaders say risk aversion blocks innovation, urging tech adoption for faster drug development.
The Economic Times · 1m
NFI Lists Unapproved Drugs, DCGI Demands Explanation
India's National Formulary includes drugs not approved by central drug regulator, prompting DCGI to seek IPC's rationale.
The Economic Times · 1m